NEW YORK, Sept. 17 (GenomeWeb News) - Tecan and Invitrogen today announced a non-exclusive collaboration to create products for use in sample preparation, microarrays, and cell-based assays.

New product combinations will link Invitrogen's research kits with Tecan's laboratory automation products, multimode detection devices, and microarray systems that both companies will market.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.